Literature DB >> 15834907

Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.

Elizabeth A Sadowski1, Frederick Kelcz.   

Abstract

PURPOSE: To determine the chance of malignancy in lesions classified as "probably benign" by dynamic magnetic resonance imaging (MRI), in a heterogeneous population.
MATERIALS AND METHODS: Reports from 473 patients, from March 1994 to March 2002, who underwent breast MRI were retrospectively reviewed. A total of 79 patients (17%) had lesions classified as probably benign after the MRI, which required further imaging follow-up. We evaluated subsequent MRI, mammographic reports, and clinical follow-up in these patients and established the frequency of malignancy in this group.
RESULTS: MRI classified probably benign lesion were diagnosed in 79 women because of focal or diffuse mild enhancement and benign dynamic enhancement curves in the area of the mammographic abnormality, or because of the presence of microcalcifications on the mammogram, or because of incidental enhancing lesions. Two-year radiographic and/or clinical follow-up was available in 68 women. On follow-up, four women (6%) were diagnosed with cancer between 14 and 18 months after the initial MRI.
CONCLUSION: Patients with a lesion assessed as probably benign by dynamic contrast enhanced MRI have a higher chance of malignancy than patients with probably benign lesions (Breast Imaging Reporting and Data System category 3, BI-RADS 3) seen on mammography. These patients should be informed of the increased risk of cancer and be given the option of biopsy or close follow-up.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834907     DOI: 10.1002/jmri.20312

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

1.  The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.

Authors:  M D Dorrius; R M Pijnappel; M C van der Weide Jansen; L Jansen; P Kappert; M Oudkerk; P E Sijens
Journal:  Eur Radiol       Date:  2011-11-11       Impact factor: 5.315

2.  Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Authors:  Susan P Weinstein; Lucy G Hanna; Constantine Gatsonis; Mitchell D Schnall; Mark A Rosen; Constance D Lehman
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound.

Authors:  O Sarica; F Uluc
Journal:  Br J Radiol       Date:  2014-07-01       Impact factor: 3.039

4.  Auditing a breast MRI practice: performance measures for screening and diagnostic breast MRI.

Authors:  Bethany L Niell; Sara C Gavenonis; Tina Motazedi; Jessica Cott Chubiz; Elkan P Halpern; Elizabeth A Rafferty; Janie M Lee
Journal:  J Am Coll Radiol       Date:  2014-04-29       Impact factor: 5.532

Review 5.  BI-RADS 3 Assessment on MRI: A Lesion-Based Review for Breast Radiologists.

Authors:  Derek L Nguyen; Kelly S Myers; Eniola Oluyemi; Lisa A Mullen; Babita Panigrahi; Joanna Rossi; Emily B Ambinder
Journal:  J Breast Imaging       Date:  2022-06-28

6.  Clinical implementation of a multislice high spectral and spatial resolution-based MRI sequence to achieve unilateral full-breast coverage.

Authors:  Milica Medved; Gillian M Newstead; Hiroyuki Abe; Olufunmilayo I Olopade; Akiko Shimauchi; Marta A Zamora; Gregory S Karczmar
Journal:  Magn Reson Imaging       Date:  2009-07-22       Impact factor: 2.546

7.  MR-guided breast biopsy at 3T: diagnostic yield of large core needle biopsy compared with vacuum-assisted biopsy.

Authors:  Carla Meeuwis; Jeroen Veltman; Hester N van Hall; Roel D M Mus; Carla Boetes; Jelle O Barentsz; Ritse M Mann
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

Review 8.  Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis.

Authors:  Claudio Spick; Hubert Bickel; Stephan H Polanec; Pascal A Baltzer
Journal:  Eur Radiol       Date:  2017-11-22       Impact factor: 5.315

Review 9.  BI-RADS 3: Current and Future Use of Probably Benign.

Authors:  Karen A Lee; Nishi Talati; Rebecca Oudsema; Sharon Steinberger; Laurie R Margolies
Journal:  Curr Radiol Rep       Date:  2018-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.